GO
Loading...

Johnson & Johnson

More

  • Early Glance: Pharmaceuticals companies Thursday, 10 Apr 2014 | 10:24 AM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $73.08. Bristol-Myers Squibb Co. fell$. 45 or. 9 percent, to $50.12. Hospira fell$. 56 or 1.3 percent, to $43.65.

  • Final Glance: Medical Devices companies Wednesday, 9 Apr 2014 | 6:06 PM ET

    Allergan rose $3.00 or 2.5 percent, to $120.91. Baxter International Inc. rose $1.15 or 1.6 percent, to $73.45. Boston Scientific Corp. rose$. 63 or 4.9 percent, to $13.54.

  • Final Glance: Pharmaceuticals companies Wednesday, 9 Apr 2014 | 6:06 PM ET

    Baxter International Inc. rose $1.15 or 1.6 percent, to $73.45. Bristol-Myers Squibb Co. rose $1.51 or 3.1 percent, to $50.57. Hospira rose$. 69 or 1.6 percent, to $44.21.

  • Midday Glance: Medical Devices companies Wednesday, 9 Apr 2014 | 1:15 PM ET

    Allergan rose $1.95 or 1.7 percent, to $119.86. Baxter International Inc. rose$. 62 or. 9 percent, to $72.92. Boston Scientific Corp. rose$. 47 or 3.6 percent, to $13.38.

  • Midday Glance: Pharmaceuticals companies Wednesday, 9 Apr 2014 | 1:15 PM ET

    Baxter International Inc. rose$. 62 or. 9 percent, to $72.92. Bristol-Myers Squibb Co. rose$. 87 or 1.8 percent, to $49.93. Hospira rose$. 52 or 1.2 percent, to $44.04.

  • LONDON, April 9- The World Health Organisation wants a "concerted effort" to drive down the cost of new hepatitis C drugs that offer a cure for the liver-destroying virus but are unaffordable for most infected people worldwide.

  • April 8- Alkermes Plc said it planned to seek U.S. marketing approval for its experimental drug to treat the symptoms of schizophrenia after it succeeded in a late-stage study, sending the company's shares up as much as 11 percent. The growing market for atypical antipsychotics for schizophrenia was worth $4.5 billion in the United States, Pops said.

  • Early Glance: Pharmaceuticals companies Tuesday, 8 Apr 2014 | 10:43 AM ET

    Baxter International Inc. rose$. 24 or. 3 percent, to $72.73. Johnson& Johnson rose$. 04 or percent, to $97.93. Eli Lilly& Co. rose$. 04 or. 1 percent, to $58.66.

  • Early Glance: Medical Devices companies Tuesday, 8 Apr 2014 | 10:43 AM ET

    Allergan fell$. 65 or. 5 percent, to $120.13. Baxter International Inc. rose$. 24 or. 3 percent, to $72.73. Boston Scientific Corp. fell$. 17 or 1.3 percent, to $13.05.

  • Arkansas AG asks court to reconsider drug ruling Monday, 7 Apr 2014 | 6:30 PM ET

    LITTLE ROCK, Ark.— Arkansas Attorney General Dustin McDaniel asked the state Supreme Court on Monday to reconsider its decision tossing out a $1.2 billion judgment against drugmaker Johnson& Johnson, saying justices did "significant harm" to the state and broke from 170 years of precedent.

  • Final Glance: Medical Devices companies Monday, 7 Apr 2014 | 6:01 PM ET

    Allergan fell $3.35 or 2.7 percent, to $120.77. Baxter International Inc. fell$. 44 or. 6 percent, to $72.49. Boston Scientific Corp. fell$. 28 or 2.1 percent, to $13.22.

  • Final Glance: Pharmaceuticals companies Monday, 7 Apr 2014 | 6:01 PM ET

    Baxter International Inc. fell$. 44 or. 6 percent, to $72.49. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $50.28. Hospira fell$. 37 or. 9 percent, to $43.01.

  • Midday Glance: Pharmaceuticals companies Monday, 7 Apr 2014 | 1:50 PM ET

    Baxter International Inc. rose$. 06 or. 1 percent, to $72.99. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $50.28. Hospira fell$. 55 or 1.3 percent, to $42.83.

  • Midday Glance: Medical Devices companies Monday, 7 Apr 2014 | 1:50 PM ET

    Allergan fell $3.31 or 2.7 percent, to $120.81. Baxter International Inc. rose$. 06 or. 1 percent, to $72.99. Boston Scientific Corp. fell$. 15 or 1.1 percent, to $13.35.

  • April 2- Bill Gates, the World Bank and other donors are stepping up efforts to fight neglected tropical diseases in Africa and other low-income regions with a $240 million injection of new funding. The new collaboration includes $50 million from the Bill& Melinda Gates Foundation and $50 million from the Children's Investment Fund Foundation.

  • Midday Movers: Amgen, Biogen, Priceline & More Monday, 31 Mar 2014 | 12:18 PM ET

    Take a look at some of Monday's midday movers:

  • WASHINGTON, March 31- Bariatric weight loss surgery on obese patients with type 2 diabetes helped many to get their blood sugar to healthy levels and to no longer require any diabetes medicines, including insulin, three years after the procedure, according to data presented at a major medical meeting on Monday.

  • *All retail supplies recalled in U.S. and Puerto Rico. LONDON, March 27- GlaxoSmithKline is recalling all supplies of its non-prescription weight-loss drug Alli in the United States and Puerto Rico after customers reported finding other pills and tablets in some bottles.

  • Momentum stocks begin dipping as balloon deflates Thursday, 27 Mar 2014 | 10:48 AM ET
    Trader on the floor of the New York Stock Exchange.

    The momentum names once again got hit with no regard for quality or prospects and, despite some recovery in morning trading, anxiety remains.

  • Cramer: Are these stocks too darn cheap? Tuesday, 25 Mar 2014 | 6:01 PM ET

    Jim Cramer has noticed a remarkable transformation in the market over the last few days. Investors are buying value.

Most Popular Video

Wednesday, 16 Apr 2014 | 12:00 AM ET

GM unveils new models, hopes for strong sales this year After massive recalls, General Motors is pushing forward with new car models unveiled at the 2014 New York International Auto Show. CNBC's Phil LeBeau explains.

Friday, 11 Apr 2014 | 7:23 AM ET

Former Fed Chairman Ben Bernanke challenges Raghuram Rajan, Reserve Bank of India governor on his views about monetary policies, reports CNBC's Michelle Caruso-Cabrera.

Tuesday, 15 Apr 2014 | 5:40 PM ET

Jonathan Geller, BGR president and editor-in-chief, weighs in on the specifications for Amazon's newly announced 3-D smartphone.